LLY  valuation analysis

Basics
Name: Eli Lilly and Company
Description: Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Oct 27, 2020
Market cap: $188.40B (33rd)
Sales(TTM): $23.21B (100th)
Earnings(TTM): $5.57B (41st)

Value
FFER: 1.43*
Actual price: $206.81
* Earnings were reported Jan 29, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-03-05
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Sales / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Book / MarketCap
Eli Lilly and Company
"Drug Manufacturers-General" industry
Equity / Assets
Eli Lilly and Company
"Drug Manufacturers-General" industry